[HTML][HTML] Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing
…, BPC Hoppe, PC Clahsen, KW Maas… - Journal of Thoracic …, 2020 - Elsevier
Introduction Frequently, patients with locally advanced or metastatic NSCLC are screened for
mutations and fusions. In most laboratories, molecular workup includes a multitude of tests: …
mutations and fusions. In most laboratories, molecular workup includes a multitude of tests: …
Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
CCM Pitz, KW Maas, HA Van Swieten… - The Annals of thoracic …, 2002 - Elsevier
Background. The role of surgery after neoadjuvant chemotherapy in patients with stage IIIB
non-small cell lung cancer (NSCLC) remains unclear. Methods. A prospective multicenter …
non-small cell lung cancer (NSCLC) remains unclear. Methods. A prospective multicenter …
Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined …
KW Maas, I van der Lee, K Bolt, P Zanen… - Lung Cancer, 2003 - Elsevier
Introduction: Lung cancer is the leading cause of cancer mortality. Chemotherapy, ideally a
platinum-based regimen as part of combined modality treatment, is appropriate for selected …
platinum-based regimen as part of combined modality treatment, is appropriate for selected …
Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer
KW Maas, SY El Sharouni, EF Smit… - Current opinion in …, 2007 - journals.lww.com
Concurrent chemoradiotherapy in combination with full-dose chemotherapy should be the
standard of care for nonsmall cell lung cancer stage IIIA/B. Surgery is still experimental, but …
standard of care for nonsmall cell lung cancer stage IIIA/B. Surgery is still experimental, but …
Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study
KW Maas, SY El Sharouni, ECJ Phernambucq… - Anticancer …, 2010 - ar.iiarjournals.org
Background: This prospective study analyzed the feasibility and efficacy of weekly concurrent
chemoradiation (docetaxel/cisplatin) followed by surgery. The primary endpoint was …
chemoradiation (docetaxel/cisplatin) followed by surgery. The primary endpoint was …
Lung cancer staging by endobronchial ultrasound with transbronchial needle aspiration
NJ Claessens, KW Maas, JA Kummer… - Nederlands Tijdschrift …, 2012 - europepmc.org
[Lung cancer staging by endobronchial ultrasound with transbronchial needle aspiration]. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer
N Claessens, K Maas, A Kummer, F Schramel - 2012 - Eur Respiratory Soc
Background: In lung cancer minimally invasive staging of the mediastinum with endobronchial
ultrasonography with transbronchial needle aspiration (EBUS-TBNA) has become an …
ultrasonography with transbronchial needle aspiration (EBUS-TBNA) has become an …
[HTML][HTML] Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3 …
…, E Pouw, J Belderbos, K Maas… - Clinical and …, 2022 - Elsevier
Introduction Concurrent chemoradiation followed by immunotherapy is the standard of care
for patients with stage III non-small cell lung cancer (NSCLC). Prior to the introduction of …
for patients with stage III non-small cell lung cancer (NSCLC). Prior to the introduction of …
[HTML][HTML] P3-256: The prognostic value of the Standardized Uptake Value (SUV) of FDG-PET in patients with stage I and II non-small cell lung cancer (NSCLC) treated …
MJ Rops, KW Maas, FM Schramel… - Journal of Thoracic …, 2007 - jto.org
Methods: Primary endpoint of this retrospective study was time to recurrence after radical
resection of stage I and II NSCLC in relation to the SUV on FDG-PET, pre-operatively used for …
resection of stage I and II NSCLC in relation to the SUV on FDG-PET, pre-operatively used for …
[CITATION][C] Minimal (invasive) staging techniques in Non-Small Cell Lung Cancer stage III
KW Maas, FMNH Schramel, EF Smit, JC Grutters - Clinical studies in Non-Small Cell Lung …